Global Placenta Market is worth USD 67.7 Billion in 2022 and is estimated to grow at a CAGR of 12.4% in the forecasted period. The forecasted revenue hints at a growth of around 153.5 billion USD by 2029. The placenta is an essential vascular organ in most mammals that develops during pregnancy, providing vital functions like metabolic exchanges which assists for fatal growth and development. Not just during pregnancy, but also placenta products have found application in various consumer products like cosmetics and hair care products. With recent increase in the anti-aging solutions market, the demand for placenta market has also increased. The earlier use of the placenta was restricted to wound care and wound healing, which was aided by stem cells found in the placenta. This led to an emerging interest in the placenta market. Effective treatments for chronic illnesses are projected to be made possible by such recent developments. Investment in R&D has been the major strength of the market. In 2022, there were over 2,000 clinical trials involving stem cells underway worldwide. Also, some recent researches have focused on its potential therapeutic applications in a variety of diseases, including heart disease, stroke, diabetes, and neurodegenerative diseases. Ethical concerns have hampered the rapid growth of the market, but its increasing prospect in revolutionising humans, have appealed to a lot of researchers. Asia Pacific has been leading the market share for the placenta market. Japan, South Korea, and China are amongst the countries who have showed huge progress in placenta research and development, particularly in the pharmaceutical and cosmetics sectors. These countries have invested heavily in surge production of placenta-derived products, contributing to market growth in the region. Additionally, the Asia-Pacific region has a large population base and a strong cultural emphasis on skincare and anti-aging products, which is further driving the market.To know about the Research Methodology :- Request Free Sample Report
Placenta Market Dynamics:
The placenta market has been experiencing huge growth especially because of its increasing awareness and attractiveness of placenta-based products and other products which have found application in healthcare. Placenta-derived materials have various bioactive compounds, like cytokines, and stem cells, which have proven ability for regenerative and healing applications. Also, the growing call for alternative and herbal treatments in healthcare fuels the market. Placenta-based products are considered natural and often perceived as a safer alternative to artificial tablets, attracting consumers who prefer holistic and herbal strategies to fitness and wellbeing. Moreover, the expanding programs of placenta-derived substances in the cosmetics and personal care enterprise drives the placenta market. Placenta extracts are believed to have anti-aging, moisturizing, and pores and skin rejuvenation properties, leading to their application into skin care merchandise, hair care formulations, and anti-ageing creams. Also, technological improvements inside the processing and maintenance of placenta-derived materials have boosted market growth. Improved strategies for extracting, sterilizing, freeze-drying, and storing placenta substances have stronger their protection, efficacy, and shelf life, allowing wider distribution and usage. Market Challenges The placenta market faces many challenges in the placenta market. One of the great challenges is the moral and cultural concerns related to the use of placenta-derived substances. Some consumers have reservations regarding the sourcing and utilization of placenta, considering it as a sensitive and sacred part of the childbirth procedure. These ethical concerns lead to public debates, regulatory regulations, or constrained attractiveness, hindering the marketplace's expansion. Another challenge which placenta market faces is regarding the variability and inconsistency of placenta-derived materials. Each placenta is precise, and factors consisting of maternal fitness, gestational age, and processing techniques can have an effect on the composition and potency of the derived materials. This variability poses challenges in standardization, making it a tough task for the companies working in this field. The cost of such products is too high for common population, which becomes a huge restriction for the market growth. The processing, preservation, and testing of placenta materials require specialized system, centres, and knowledge, which leads to high manufacturing costs. Also, regulatory demanding situations and legal issues hinder the placenta market's boom. Different nations and regions have various guidelines and restrictions concerning the collection, processing, and distribution of placenta-derived substances. Complying with these various regulations, obtaining necessary licenses, and navigating complex legal frameworks pose extensive challenges for market players.Market Trends:
The placenta marketplace is witnessing numerous noteworthy developments which are shaping its trends. One prominent trend has been the growing utilization of placenta-derived materials in regenerative remedy and tissue engineering. Researchers and healthcare specialists are exploring the capacity of placental cells, growth elements, and extracellular matrix components for tissue restore, wound recuperation, and organ regeneration. Another rising trend has been the combination of placenta-derived elements inside the beauty and skin care industry. Placenta extracts, rich in nutrients and bioactive compounds, are being incorporated into a huge variety of cosmetic and skincare merchandise. These formulations have anti-aging, moisturizing, and pores and skin rejuvenating properties, which act wonders in skin care market. Furthermore, the rise of personalised remedy and the improvement of mobile-based therapies have unfolded new avenues inside the placenta market. The idea of the usage of someone's very own placental cells or placenta-derived merchandise for personalised remedy is gaining traction. Additionally, the market is witnessing advancements in placenta processing techniques and maintenance methods. Innovations together with cryopreservation and freeze-drying are permitting better garage, transportation, and usage of placenta-derived substances whilst retaining their therapeutic houses. These technological improvements have enhanced the supply, comfort, and shelf life of placenta-primarily based products, contributing to placenta market growth. Also, the placenta market is growing recognition on sustainable and moral sourcing practices in the placenta market. Companies are emphasizing accountable series strategies, ensuring knowledgeable consent, and promoting transparency within the deliver chain. Collaborations and partnerships among research establishments, biotechnology corporations, and healthcare companies will play a huge role in the future growth of placenta market.Placenta Market Segment Analysis
by Type Porcine, Equine and Ovine are the major types in placenta market. Porcine has been the predominant type used in placenta products. Nearly half of the market share is dominated by porcine type. Equine placenta is also used in some commercial products, but it is less common than porcine placenta by Application Pharmaceuticals, Cosmetics and Supplements are the major applications in placenta market. Cosmetics have shown the highest potential amongst the other applications. The increased use of creams, serums, and other skin care products have resulted in increased application of placenta products in cosmetics segment.Placenta Market Segmentation, by End User Hospitals, Clinical and Research laboratories are the major end users in placenta market. Hospitals have dominated a majority of its market share. Research laboratories have seen an increasing share, as R&D is being of the most crucial aspect of this market. Placenta Market Segmentation, by Region Asia Pacific is the leading player in placenta market. The domination of countries like Japan, China have ensured that Asia pacific retains a huge market share. The developed healthcare ecosystem and biotechnological facilities have made this progress possible. US has been another huge market with its huge investments in research and development. Germany has been the leading European country with highest market share amongst the European countries.
Competitive Landscape
The competitive landscape of the placenta market is characterised with a complex combination of established players, rising organizations, and research establishments actively concerned in placenta-associated studies and development. Several companies have been competing in the placenta market with active innovation and huge research developments. Key partnerships and collaborations have been at the forefront in this market. The Australian Placental Blood Bank and CuraCell Biotech entered into a collaboration to develop innovative placenta-based products for wound healing and tissue regeneration. Also, some leading players in the market are Japan Bio Products, SwissMedicus AG. Japan Bio Products Co: Japan Bio Products is a leading participant inside the placenta market. The organization specializes inside the manufacturing of placenta extracts for pharmaceutical and beauty applications. They have a robust presence in Japan and have elevated their operations internationally. Lanzhou Mingde Biological Technology: Lanzhou Mingde Biological Technology is a Chinese employer that focuses on the studies, improvement, and production of placenta-based merchandise. They offer a number of placenta extracts and dietary supplements targeting diverse fitness and splendor concerns. LC Cell Co: LC Cell is a South Korean organization that specializes in placenta-primarily based merchandise for both clinical and beauty functions. They are known for his or her advanced research and innovative techniques in placenta extraction and formulation.Placenta Market Scope: Inquire before buying
Placenta Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 67.7 Bn. Forecast Period 2023 to 2029 CAGR: 12.4% Market Size in 2029: US $ 153.5 Bn. Segments Covered: by Type Porcine Equine Ovine by End User Hospitals Clinical Research laboratories by Application Pharmaceuticals Cosmetics Supplements Placenta Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest) South America (Brazil, Argetina and Rest of South America)Placenta Key Players
1. XaQuil Pharma (United States) 2. Celularity Inc. (United States) 3. CooperSurgical, Inc. (United States) 4. Biotime Inc. (United States) 5. Stem Cells Group (United States) 6. MatTek Corporation (United States) 7. Tree of Life Stem Cells (United States) 8. BIOVICI (France) 9. Placentor SAS (France) 10. VITROLIFE AB (Sweden) 11. Plasmia Biotech (Spain) 12. PromoCell GmbH (Germany) 13. Placenta Clinic (Russia) 14. Placentagen (United Kingdom) 15. Pluristem Therapeutics Inc. (Israel) 16. RegenerCell Biotechnology Co., Ltd. (China) 17. K-Stemcell Co., Ltd. (South Korea) 18. Australian Biostain Pty Ltd. (Australia) 19. Japan Tissue Engineering Co., Ltd. (Japan) 20. Organ Technologies Inc. (Japan) 21. Japan Regenerative Medicine Co., Ltd. (Japan) 22. Placenta Power (New Zealand) 23. Placenta International Co., Ltd. (Thailand) 24. Human Biologicals Institute (India) 25. JBS S.A. (Brazil)FAQ
Q.1) What is the CAGR of the Placenta Market? Ans: The CAGR for Placenta Market is 12.4% Q.2) Which are the leading companies in Placenta Market? Ans: Organ Technologies Inc, Japan Regenerative Medicine Co, and Plasmia Biotech are some of the leading companies in the Placenta Market Q.3) Which region shows maximum potential in Placenta Market Ans: Asia Pacific is expected to grow exponentially and is likely to dominate Placenta Market in future Q,4) Which is the leading region in Placenta Market? Ans: North America leads the market of Placenta Market significantly Q.5) What was the forecasted period of this report? Ans: The forecasted period for the Placenta Market research was 2023 – 2029
1. Placenta Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Placenta Market: Dynamics 2.1. Placenta Market Trends by Region 2.1.1. North America Placenta Market Trends 2.1.2. Europe Placenta Market Trends 2.1.3. Asia Pacific Placenta Market Trends 2.1.4. Middle East and Africa Placenta Market Trends 2.1.5. South America Placenta Market Trends 2.2. Placenta Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Placenta Market Drivers 2.2.1.2. North America Placenta Market Restraints 2.2.1.3. North America Placenta Market Opportunities 2.2.1.4. North America Placenta Market Challenges 2.2.2. Europe 2.2.2.1. Europe Placenta Market Drivers 2.2.2.2. Europe Placenta Market Restraints 2.2.2.3. Europe Placenta Market Opportunities 2.2.2.4. Europe Placenta Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Placenta Market Drivers 2.2.3.2. Asia Pacific Placenta Market Restraints 2.2.3.3. Asia Pacific Placenta Market Opportunities 2.2.3.4. Asia Pacific Placenta Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Placenta Market Drivers 2.2.4.2. Middle East and Africa Placenta Market Restraints 2.2.4.3. Middle East and Africa Placenta Market Opportunities 2.2.4.4. Middle East and Africa Placenta Market Challenges 2.2.5. South America 2.2.5.1. South America Placenta Market Drivers 2.2.5.2. South America Placenta Market Restraints 2.2.5.3. South America Placenta Market Opportunities 2.2.5.4. South America Placenta Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Placenta Industry 2.8. Analysis of Government Schemes and Initiatives For Placenta Industry 2.9. Placenta Market Trade Analysis 2.10. The Global Pandemic Impact on Placenta Market 3. Placenta Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Placenta Market Size and Forecast, by Type (2022-2029) 3.1.1. Porcine 3.1.2. Equine 3.1.3. Ovine 3.2. Placenta Market Size and Forecast, by End User (2022-2029) 3.2.1. Hospitals 3.2.2. Clinical 3.2.3. Research laboratories 3.3. Placenta Market Size and Forecast, by Application (2022-2029) 3.3.1. Pharmaceuticals 3.3.2. Cosmetics 3.3.3. Supplements 3.4. Placenta Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Placenta Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Placenta Market Size and Forecast, by Type (2022-2029) 4.1.1. Porcine 4.1.2. Equine 4.1.3. Ovine 4.2. North America Placenta Market Size and Forecast, by End User (2022-2029) 4.2.1. Hospitals 4.2.2. Clinical 4.2.3. Research laboratories 4.3. North America Placenta Market Size and Forecast, by Application (2022-2029) 4.3.1. Pharmaceuticals 4.3.2. Cosmetics 4.3.3. Supplements 4.4. North America Placenta Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Placenta Market Size and Forecast, by Type (2022-2029) 4.4.1.1.1. Porcine 4.4.1.1.2. Equine 4.4.1.1.3. Ovine 4.4.1.2. United States Placenta Market Size and Forecast, by End User (2022-2029) 4.4.1.2.1. Hospitals 4.4.1.2.2. Clinical 4.4.1.2.3. Research laboratories 4.4.1.3. United States Placenta Market Size and Forecast, by Application (2022-2029) 4.4.1.3.1. Pharmaceuticals 4.4.1.3.2. Cosmetics 4.4.1.3.3. Supplements 4.4.2. Canada 4.4.2.1. Canada Placenta Market Size and Forecast, by Type (2022-2029) 4.4.2.1.1. Porcine 4.4.2.1.2. Equine 4.4.2.1.3. Ovine 4.4.2.2. Canada Placenta Market Size and Forecast, by End User (2022-2029) 4.4.2.2.1. Hospitals 4.4.2.2.2. Clinical 4.4.2.2.3. Research laboratories 4.4.2.3. Canada Placenta Market Size and Forecast, by Application (2022-2029) 4.4.2.3.1. Pharmaceuticals 4.4.2.3.2. Cosmetics 4.4.2.3.3. Supplements 4.4.3. Mexico 4.4.3.1. Mexico Placenta Market Size and Forecast, by Type (2022-2029) 4.4.3.1.1. Porcine 4.4.3.1.2. Equine 4.4.3.1.3. Ovine 4.4.3.2. Mexico Placenta Market Size and Forecast, by End User (2022-2029) 4.4.3.2.1. Hospitals 4.4.3.2.2. Clinical 4.4.3.2.3. Research laboratories 4.4.3.3. Mexico Placenta Market Size and Forecast, by Application (2022-2029) 4.4.3.3.1. Pharmaceuticals 4.4.3.3.2. Cosmetics 4.4.3.3.3. Supplements 5. Europe Placenta Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Placenta Market Size and Forecast, by Type (2022-2029) 5.1. Europe Placenta Market Size and Forecast, by End User (2022-2029) 5.1. Europe Placenta Market Size and Forecast, by Application (2022-2029) 5.4. Europe Placenta Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Placenta Market Size and Forecast, by Type (2022-2029) 5.4.1.2. United Kingdom Placenta Market Size and Forecast, by End User (2022-2029) 5.4.1.3. United Kingdom Placenta Market Size and Forecast, by Application (2022-2029) 5.4.2. France 5.4.2.1. France Placenta Market Size and Forecast, by Type (2022-2029) 5.4.2.2. France Placenta Market Size and Forecast, by End User (2022-2029) 5.4.2.3. France Placenta Market Size and Forecast, by Application (2022-2029) 5.4.3. Germany 5.4.3.1. Germany Placenta Market Size and Forecast, by Type (2022-2029) 5.4.3.2. Germany Placenta Market Size and Forecast, by End User (2022-2029) 5.4.3.3. Germany Placenta Market Size and Forecast, by Application (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Placenta Market Size and Forecast, by Type (2022-2029) 5.4.4.2. Italy Placenta Market Size and Forecast, by End User (2022-2029) 5.4.4.3. Italy Placenta Market Size and Forecast, by Application (2022-2029) 5.4.5. Spain 5.4.5.1. Spain Placenta Market Size and Forecast, by Type (2022-2029) 5.4.5.2. Spain Placenta Market Size and Forecast, by End User (2022-2029) 5.4.5.3. Spain Placenta Market Size and Forecast, by Application (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Placenta Market Size and Forecast, by Type (2022-2029) 5.4.6.2. Sweden Placenta Market Size and Forecast, by End User (2022-2029) 5.4.6.3. Sweden Placenta Market Size and Forecast, by Application (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Placenta Market Size and Forecast, by Type (2022-2029) 5.4.7.2. Austria Placenta Market Size and Forecast, by End User (2022-2029) 5.4.7.3. Austria Placenta Market Size and Forecast, by Application (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Placenta Market Size and Forecast, by Type (2022-2029) 5.4.8.2. Rest of Europe Placenta Market Size and Forecast, by End User (2022-2029) 5.4.8.3. Rest of Europe Placenta Market Size and Forecast, by Application (2022-2029) 6. Asia Pacific Placenta Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Placenta Market Size and Forecast, by Type (2022-2029) 6.2. Asia Pacific Placenta Market Size and Forecast, by End User (2022-2029) 6.3. Asia Pacific Placenta Market Size and Forecast, by Application (2022-2029) 6.4. Asia Pacific Placenta Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Placenta Market Size and Forecast, by Type (2022-2029) 6.4.1.2. China Placenta Market Size and Forecast, by End User (2022-2029) 6.4.1.3. China Placenta Market Size and Forecast, by Application (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Placenta Market Size and Forecast, by Type (2022-2029) 6.4.2.2. S Korea Placenta Market Size and Forecast, by End User (2022-2029) 6.4.2.3. S Korea Placenta Market Size and Forecast, by Application (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Placenta Market Size and Forecast, by Type (2022-2029) 6.4.3.2. Japan Placenta Market Size and Forecast, by End User (2022-2029) 6.4.3.3. Japan Placenta Market Size and Forecast, by Application (2022-2029) 6.4.4. India 6.4.4.1. India Placenta Market Size and Forecast, by Type (2022-2029) 6.4.4.2. India Placenta Market Size and Forecast, by End User (2022-2029) 6.4.4.3. India Placenta Market Size and Forecast, by Application (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Placenta Market Size and Forecast, by Type (2022-2029) 6.4.5.2. Australia Placenta Market Size and Forecast, by End User (2022-2029) 6.4.5.3. Australia Placenta Market Size and Forecast, by Application (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Placenta Market Size and Forecast, by Type (2022-2029) 6.4.6.2. Indonesia Placenta Market Size and Forecast, by End User (2022-2029) 6.4.6.3. Indonesia Placenta Market Size and Forecast, by Application (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Placenta Market Size and Forecast, by Type (2022-2029) 6.4.7.2. Malaysia Placenta Market Size and Forecast, by End User (2022-2029) 6.4.7.3. Malaysia Placenta Market Size and Forecast, by Application (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Placenta Market Size and Forecast, by Type (2022-2029) 6.4.8.2. Vietnam Placenta Market Size and Forecast, by End User (2022-2029) 6.4.8.3. Vietnam Placenta Market Size and Forecast, by Application (2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Placenta Market Size and Forecast, by Type (2022-2029) 6.4.9.2. Taiwan Placenta Market Size and Forecast, by End User (2022-2029) 6.4.9.3. Taiwan Placenta Market Size and Forecast, by Application (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Placenta Market Size and Forecast, by Type (2022-2029) 6.4.10.2. Rest of Asia Pacific Placenta Market Size and Forecast, by End User (2022-2029) 6.4.10.3. Rest of Asia Pacific Placenta Market Size and Forecast, by Application (2022-2029) 7. Middle East and Africa Placenta Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Placenta Market Size and Forecast, by Type (2022-2029) 7.2. Middle East and Africa Placenta Market Size and Forecast, by End User (2022-2029) 7.3. Middle East and Africa Placenta Market Size and Forecast, by Application (2022-2029) 7.4. Middle East and Africa Placenta Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Placenta Market Size and Forecast, by Type (2022-2029) 7.4.1.2. South Africa Placenta Market Size and Forecast, by End User (2022-2029) 7.4.1.3. South Africa Placenta Market Size and Forecast, by Application (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Placenta Market Size and Forecast, by Type (2022-2029) 7.4.2.2. GCC Placenta Market Size and Forecast, by End User (2022-2029) 7.4.2.3. GCC Placenta Market Size and Forecast, by Application (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Placenta Market Size and Forecast, by Type (2022-2029) 7.4.3.2. Nigeria Placenta Market Size and Forecast, by End User (2022-2029) 7.4.3.3. Nigeria Placenta Market Size and Forecast, by Application (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Placenta Market Size and Forecast, by Type (2022-2029) 7.4.4.2. Rest of ME&A Placenta Market Size and Forecast, by End User (2022-2029) 7.4.4.3. Rest of ME&A Placenta Market Size and Forecast, by Application (2022-2029) 8. South America Placenta Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Placenta Market Size and Forecast, by Type (2022-2029) 8.2. South America Placenta Market Size and Forecast, by End User (2022-2029) 8.3. South America Placenta Market Size and Forecast, by Application(2022-2029) 8.4. South America Placenta Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Placenta Market Size and Forecast, by Type (2022-2029) 8.4.1.2. Brazil Placenta Market Size and Forecast, by End User (2022-2029) 8.4.1.3. Brazil Placenta Market Size and Forecast, by Application (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Placenta Market Size and Forecast, by Type (2022-2029) 8.4.2.2. Argentina Placenta Market Size and Forecast, by End User (2022-2029) 8.4.2.3. Argentina Placenta Market Size and Forecast, by Application (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Placenta Market Size and Forecast, by Type (2022-2029) 8.4.3.2. Rest Of South America Placenta Market Size and Forecast, by End User (2022-2029) 8.4.3.3. Rest Of South America Placenta Market Size and Forecast, by Application (2022-2029) 9. Global Placenta Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Placenta Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. XaQuil Pharma (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Celularity Inc. (United States) 10.3. CooperSurgical, Inc. (United States) 10.4. Biotime Inc. (United States) 10.5. Stem Cells Group (United States) 10.6. MatTek Corporation (United States) 10.7. Tree of Life Stem Cells (United States) 10.8. BIOVICI (France) 10.9. Placentor SAS (France) 10.10. VITROLIFE AB (Sweden) 10.11. Plasmia Biotech (Spain) 10.12. PromoCell GmbH (Germany) 10.13. Placenta Clinic (Russia) 10.14. Placentagen (United Kingdom) 10.15. Pluristem Therapeutics Inc. (Israel) 10.16. RegenerCell Biotechnology Co., Ltd. (China) 10.17. K-Stemcell Co., Ltd. (South Korea) 10.18. Australian Biostain Pty Ltd. (Australia) 10.19. Japan Tissue Engineering Co., Ltd. (Japan) 10.20. Organ Technologies Inc. (Japan) 10.21. Japan Regenerative Medicine Co., Ltd. (Japan) 10.22. Placenta Power (New Zealand) 10.23. Placenta International Co., Ltd. (Thailand) 10.24. Human Biologicals Institute (India) 11. Key Findings 12. Industry Recommendations 13. Placenta Market: Research Methodology 14. Terms and Glossary